CC BY-NC-ND 4.0 · Laryngorhinootologie 2018; 97(S 02): S197
DOI: 10.1055/s-0038-1640393
Abstracts
Otologie: Otology

Rare middle ear tumor

R Jadeed
1   Uniklinik RWTH Aachen University, Aachen
,
AK Otremba
2   Klinik für Hals-Nasen-Ohrenheilkunde und Plastische Kopf- und Halschirurgie, Uni, Aachen
,
T Braunschweig
3   RWTH Aachen University, Aachen
,
M Westhofen
2   Klinik für Hals-Nasen-Ohrenheilkunde und Plastische Kopf- und Halschirurgie, Uni, Aachen
› Author Affiliations
› Further Information
Also available at
 
 

    Background:

    Carcinoid tumors of the middle ear are very rare and belong to neuroendocrine tumors. It has been classified as a indolent malignancy (well-differentiated neuroendocrine carcinoma). In the literature since Murphy et al. 1980 only about 54 cases were published.

    Case report:

    We report a 37-year-old patient who presented with a recurrent cholesteatoma at the richt ear.

    The patient reported a recurrent otorrhea and a hearing loss on the right side. In audiometry showed a combined hearing loss with moderate inner ear involvement. Furthermore, a tympanoplasty type IIIa with radical cavity revision, myringotomy and long-term ventilation tube Insertion performed on the right ear. Intraoperatively showed a signal polyp in the tympanic cavity as well as a recurrent cholesteatoma with bone destruction.

    Histological examination demonstrated a neuroendocrine adenoma of the middle ear (signal polyp biopsy) and a cholesteatoma. Immunohistochemical evaluation revealed a predominantly negative immune response for markers CK7 and p63. The mitosis rate per 2 square millimeters was less than 1 mitosis.

    Postoperative staging did not reveal any cervical or distant metastases of the tumor, so further neck dissection was not required.

    Conclusion:

    Complete surgical removal of the tumor is considered the treatment of choice for treating neuroendocrine tumors of the middle ear for primary and metastatic carcinoids. Tympanomastoidectomy or radical mastoidectomy is then recommended.

    A modified radical or selective neck dissection is used to remove cervical lymphoid metastases in metastatic cases.


    #

    No conflict of interest has been declared by the author(s).

    Dr.(Syr) Rawad Jadeed
    Uniklinik RWTH Aachen,
    Reutershagweg 21, 52074,
    Aachen

    Publication History

    Publication Date:
    18 April 2018 (online)

    © 2018. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

    Georg Thieme Verlag KG
    Stuttgart · New York